ICAM1 and breast carcinoma: Our current findings suggest for the first time that breast cancer–expressed ICAM-1 accounts for the susceptibility of breast cancer CTCs entrapped inside lung vessels to intravascular killing by these neutrophils, most probably as they circulate through these vessels.